Immatics Competitors and Similar CompaniesClear all
Immatics's competitors and similar companies include Eureka Therapeutics and CaroGen.
 Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. |  Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
| ||
Founding Date | Founding Date N/A | Founding Date 2006 | Founding Date 2012 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US | Locations Emeryville, US HQ | Locations Farmington, US HQ |
Employees | Employees 29723% increase | Employees 432% decrease | Employees 12 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 45m (about 6 years ago) | Latest funding round $ 1.4m (about 7 years ago) |
Total funding raised | Total funding raised $ 267.3m | Total funding raised $ 130.4m | Total funding raised $ 1.6m |
For sources of this data, please see the company profile
View Company Profiles
Eureka Therapeutics
HQ
Emeryville, US
Employees
43↓ 2% decrease
Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.
View company
CaroGen
HQ
Farmington, US
Employees
12
CaroGen is a biopharmaceutical company specializing in immunotherapy.
View company